These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program. Gilbert EM Am J Cardiol; 2004 May; 93(9A):30B-4B. PubMed ID: 15144934 [TBL] [Abstract][Full Text] [Related]
28. Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study. Ramaswamy K Card Electrophysiol Rev; 2003 Sep; 7(3):229-32. PubMed ID: 14739719 [TBL] [Abstract][Full Text] [Related]
29. beta-blocker improvement in diastolic performance: the yin and yang of ventricular function changes. Eichhorn EJ; Grayburn PA Am Heart J; 2000 Apr; 139(4):584-6. PubMed ID: 10740138 [No Abstract] [Full Text] [Related]
30. Beta-adrenergic blocking drugs in severe heart failure. Fowler M Rev Cardiovasc Med; 2002; 3 Suppl 3():S20-6. PubMed ID: 12447158 [TBL] [Abstract][Full Text] [Related]
31. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014 [TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation. Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469 [TBL] [Abstract][Full Text] [Related]
33. Contemporary medical management of left ventricular dysfunction and congestive heart failure. Teo KK; Ignaszewski AP; Gutierrez R; Hill KL; Martin SL; Calhoun HP; Humen DP; Montague TJ Can J Cardiol; 1992; 8(6):611-9. PubMed ID: 1354569 [TBL] [Abstract][Full Text] [Related]
34. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988 [TBL] [Abstract][Full Text] [Related]
35. Special considerations for carvedilol use in heart failure. Yancy CW Am J Cardiol; 2004 May; 93(9A):64B-8B. PubMed ID: 15144941 [TBL] [Abstract][Full Text] [Related]